AID Logo

Directory >> Michael Chung, MD, MPH


Michael Chung, MD, MPH

  • Associate Professor, Departments of Medicine and Global Health
  • Adjunct Associate Professor, Department of Epidemiology
  • Director, TREE (Treatment, Research, and Expert Education)
    University of Washington
  • Co-Director, Department of Global Health E-Learning Initiative

Dr. Chung has been involved in HIV treatment and care, field epidemiology research, and medical education at field sites in Nairobi, Kenya and Hanoi, Vietnam since 2002. He has led several randomized controlled trials on a variety of topics, including perinatal transmission of HIV, adherence to antiretroviral medications, and treatment of cervical intraepithelial neoplasia among HIV-positive women. In 2004, Dr. Chung co-founded the Coptic Hope Center for Infectious Diseases, an HIV clinic in Nairobi, which is one of the largest single-site antiretroviral treatment centers in Kenya. He is the Director of the Treatment, Research, and Expert Education (TREE) program at the University of Washington, which is dedicated to addressing the health needs of people living in resource-limited settings through quality medical care, academic research, training, and education ( Through TREE, Dr. Chung offers a Global HIV Medicine Ele ctive as well as general rotations for medical students in Kenya and Vietnam.

Based full-time in Nairobi, Kenya, Dr. Chung's current interests include cervical cancer screening and treatment of HIV-infected women, education of health care workers in resource-limited settings through the internet, and adherence to antiretroviral medications and consequent development and transmission of drug resistance.

Reserach interests

  • Cervical cancer screening and treatment among HIV-positive women
  • Antiretroviral resistance testing using an oligonucleotide ligation assay

Selected Publications

De Vuyst H, Mugo NR, Franceschi S, McKenzie K, Tenet V, Njoroge J, Rana FS, Sakr SR, Snijders PJ, Chung MH. Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya. PLoS One. 2014;9(10):e111037. PubMed PMID: 25343563; PubMed Central PMCID: PMC4208814.
PubMed Abstract

Van der Kop ML, Ekstrom AM, Awiti-Ujiji O, Chung MH, Mahal D, Thabane L, Gelmon L, Kimani J, Lester RT. Factors Associated with Attrition from HIV Care During the First Year After Antiretroviral Therapy Initiation in Kenya. Journal of AIDS and Clinical Research. 2014 September 30; 5:354.

Chung MH, Beck IA, Dross S, Tapia K, Kiarie JN, Richardson BA, Overbaugh J, Sakr SR, John-Stewart GC, Frenkel LM. Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya. J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):246-53. PubMed PMID: 25140907; NIHMSID: NIHMS618891; PubMed Central PMCID: PMC4197120.
PubMed Abstract

van Zyl GU, Frenkel LM, Chung MH, Preiser W, Mellors JW, Nachega JB. Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits. AIDS. 2014 Nov 28;28(18):2643-8. PubMed PMID: 25493592.
PubMed Abstract

Chung MH, McKenzie KP, De Vuyst H, Richardson BA, Rana F, Pamnani R, Njoroge JW, Nyongesa-Malava E, Sakr SR, John-Stewart GC, Mugo NR. (2013). Comparing Pap smear, VIA, and HPV cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy. AIDS, 27(18), 2909-2919. PMCID: 23842133.
PubMed Abstract

Chung MH, Richardson BA, Tapia K, et al. A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med. 2011; 8(3): e1000422. PMCID: PMC3046986.
PubMed Abstract

Chung MH, Severynen AO, Hals MP, Harrington RD, Spach DH, Kim HN. (2012). Offering an American Graduate Medical HIV Course to Health Care Workers in Resource-Limited Settings via the Internet. PLoS ONE. 7(12): e52663. PMCID: PMC3527561..
PubMed Abstract

De Vuyst H, Chung MH, Baussano I, Mugo NR, Tenet V, van Kemenade FJ, Rana FS, Sakr SR, Meijer CJLM, Snijders PJF, Franceschi S. (2013). Comparison of HPV-DNA testing in exfoliated cells and tissue biopsies among HIV-positive women in Kenya. International Journal of Cancer, e-pub Feb 27 2013. PMCID: PMC3707962.
PubMed Abstract

Marson KG, Tapia K, Kohler P, McGrath CJ, John-Stewart GC, Richardson BA, Njoroge JW, Kiarie JN, Sakr SR,Chung MH. (2013). Male, mobile, and moneyed: loss to follow-up vs. transfer of care in an urban African antiretroviral treatment clinic. PLOS ONE. 8(10): e78900. PMCID: PMC3812001. Van der Kop ML, Karanja S, Thabane L, Marra C, Chung MH, Gelmon L, Kimani J, Lester RT. (2012). In-depth analysis of patient-clinician cell phone communication during the WelTel Kenya1 antiretroviral adherence trial. PLoS ONE, 7(9): e46033. PMCID: PMC3457960.
PubMed Abstract

Lester RT, Mills EJ, Kariri A, Ritvo P, Chung MH, et al. The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials. 2009; 10: 87.PMCID: PMC2760542.
PubMed Abstract

to top